vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $207.8M, roughly 1.3× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 16.6%, a 40.8% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $76.6M).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
ALAB vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $207.8M |
| Net Profit | $45.0M | $119.2M |
| Gross Margin | 75.6% | — |
| Operating Margin | 24.7% | 52.2% |
| Net Margin | 16.6% | 57.4% |
| Revenue YoY | 91.8% | — |
| Net Profit YoY | 82.0% | 330.1% |
| EPS (diluted) | $0.25 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | — | ||
| Q3 25 | $230.6M | $207.8M | ||
| Q2 25 | $191.9M | — | ||
| Q1 25 | $159.4M | — | ||
| Q4 24 | $141.1M | — | ||
| Q3 24 | $113.1M | $0 | ||
| Q2 24 | $76.8M | $0 | ||
| Q1 24 | $65.3M | $0 |
| Q4 25 | $45.0M | — | ||
| Q3 25 | $91.1M | $119.2M | ||
| Q2 25 | $51.2M | — | ||
| Q1 25 | $31.8M | — | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $-7.6M | $-51.8M | ||
| Q2 24 | $-7.5M | $-52.8M | ||
| Q1 24 | $-93.0M | $-39.6M |
| Q4 25 | 75.6% | — | ||
| Q3 25 | 76.2% | — | ||
| Q2 25 | 75.8% | — | ||
| Q1 25 | 74.9% | — | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 77.7% | — | ||
| Q2 24 | 77.9% | — | ||
| Q1 24 | 77.4% | — |
| Q4 25 | 24.7% | — | ||
| Q3 25 | 24.0% | 52.2% | ||
| Q2 25 | 20.7% | — | ||
| Q1 25 | 7.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | -7.9% | — | ||
| Q2 24 | -31.7% | — | ||
| Q1 24 | -127.1% | — |
| Q4 25 | 16.6% | — | ||
| Q3 25 | 39.5% | 57.4% | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | -6.7% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | -142.5% | — |
| Q4 25 | $0.25 | — | ||
| Q3 25 | $0.50 | $1.33 | ||
| Q2 25 | $0.29 | — | ||
| Q1 25 | $0.18 | — | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $-0.05 | $-0.60 | ||
| Q2 24 | $-0.05 | $-0.68 | ||
| Q1 24 | $-1.77 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $1.1B |
| Total Assets | $1.5B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | — | ||
| Q3 25 | $140.4M | $786.9M | ||
| Q2 25 | $162.3M | — | ||
| Q1 25 | $86.4M | — | ||
| Q4 24 | $79.6M | — | ||
| Q3 24 | $126.1M | $920.0M | ||
| Q2 24 | $421.1M | $701.7M | ||
| Q1 24 | $696.1M | $698.8M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $964.8M | — | ||
| Q3 24 | $889.6M | $1.2B | ||
| Q2 24 | $845.3M | $931.7M | ||
| Q1 24 | $808.8M | $935.3M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $983.1M | $1.2B | ||
| Q2 24 | $915.5M | $973.7M | ||
| Q1 24 | $864.9M | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $142.2M |
| Free Cash FlowOCF − Capex | $76.6M | $142.2M |
| FCF MarginFCF / Revenue | 28.3% | 68.4% |
| Capex IntensityCapex / Revenue | 6.9% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.12× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | — | ||
| Q3 25 | $78.2M | $142.2M | ||
| Q2 25 | $135.4M | — | ||
| Q1 25 | $10.5M | — | ||
| Q4 24 | $39.7M | — | ||
| Q3 24 | $63.5M | $-49.2M | ||
| Q2 24 | $29.8M | $-32.9M | ||
| Q1 24 | $3.7M | $-43.8M |
| Q4 25 | $76.6M | — | ||
| Q3 25 | $65.9M | $142.2M | ||
| Q2 25 | $133.3M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $24.3M | — | ||
| Q3 24 | $46.8M | $-49.7M | ||
| Q2 24 | $28.5M | $-33.9M | ||
| Q1 24 | $228.0K | $-45.1M |
| Q4 25 | 28.3% | — | ||
| Q3 25 | 28.6% | 68.4% | ||
| Q2 25 | 69.5% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 41.4% | — | ||
| Q2 24 | 37.1% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 5.3% | 0.0% | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 14.8% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 5.2% | — |
| Q4 25 | 2.12× | — | ||
| Q3 25 | 0.86× | 1.19× | ||
| Q2 25 | 2.64× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 1.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
